Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma is a promising and cost-effective treatment for hair and skin issues in older adults in India.

Placenta products might help with hair loss, but more research is needed.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

PRP combined with minoxidil is the most effective treatment for hair growth in androgenetic alopecia.

The supplement with Serenoa repens and Pygeum africanum significantly increased active hair growth and decreased rest phase hair in post-menopausal women with hair loss, with only mild digestive side effects.

Topical minoxidil improved hair loss in a patient when used consistently.

AGA more common in men, increases with age, linked to family history, hypertension, dyslipidemia, and smoking.

ADSC-CE treatment safely increases hair density and thickness in androgenetic alopecia patients.

Adding platelet-rich plasma improves hair density and thickness in androgenetic alopecia.

Hair loss is linked to insulin resistance in women, regardless of hormone levels.

Minoxidil and finasteride effectively treat hair loss.

Current treatments for androgenetic alopecia manage symptoms but don't cure it, and it affects social and psychological well-being.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

Older, overweight women with children and a family history of hair loss are more likely to experience female pattern hair loss.

Male and female hair loss have different genetic causes.

The document concludes that treatments for hair loss in transgender and gender-diverse individuals include topical solutions, oral medications, laser therapy, and hair restoration procedures, with progress assessed after 6-12 months.

Androgenetic alopecia involves immune cell disruptions, especially increased CD4+ T cells around hair follicles.

Minoxidil is an effective and safe treatment for common hair loss when applied to the skin, but more research is needed for optimal use.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Minoxidil, finasteride, and low-level laser light therapy are effective FDA-approved treatments for hair loss.

PCOS is common, affects fertility, and requires personalized treatment to manage symptoms and health risks.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Hormone therapy increases facial and body hair in transgender men, while hair removal improves well-being in transgender women, but cost is a barrier as insurance often doesn't cover it. Dermatologists can use various treatments for these hair issues.

The estradiol valerate/dienogest oral contraceptive helps with heavy periods, may improve acne and symptoms in PCOS, and doesn't affect sexual function.

Elderly patients frequently suffer from skin conditions, especially inflammatory ones, highlighting the need for better healthcare.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

Higher SHBG levels are linked to less severe hair loss in women, but vitamin D levels don't seem to affect hair loss.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Using different hair loss treatments at various times can improve results and reduce side effects for people with chronic hair loss.